|
Piperazine CitrateDrug - Piperazine Citrate The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Piperazine Citrate
Strength -
EQ 250MG BASE
Applicant -
IMPAX LABS
New Drug Application (NDA) Number -
080874
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Impax Laboratories Inc
Piperazine Citrate
Multifuge Eq 500mg Base/5ml Syrup; Oral
Piperazine Citrate Eq 500mg Base/5ml Syrup; Oral Piperazine Citrate Eq 500mg Base/5ml Syrup; Oral Piperazine Citrate Eq 500mg Base/5ml Syrup; Oral Vermidol Eq 500mg Base/5ml Syrup; Oral Antepar Eq 500mg Base Tablet; Oral Piperazine Citrate Eq 250mg Base Tablet; Oral Zosyn In Plastic Container Eq 60mg Base/ml;eq 7.5mg Base/ml Injectable; Injection Antepar Eq 500mg Base/5ml Syrup; Oral Bryrel Eq 500mg Base/5ml Syrup; Oral NewDrugInformation |